Navigation Links
Dr. David Greene With R3 Stem Cell Interviewed for Acclaimed Documentary
Date:5/21/2019

Dr. David Greene, Founder and CEO of R3 Stem Cell, was interviewed for a recent acclaimed documentary. The documentary, Stem Cell Therapy: Biotechnology to the Rescue, was produced by Award Winning filmmaker Dr. Elliott Haimoff.

In the documentary, which is an hour long, Dr. Greene was interviewed in regards to the safety of the procedures along with the potential for helping patients avoid potentially risky surgeries. The documentary touches on the history of stem cells, along with the current potential for the clinical use of stem cells.

R3 Stem Cell currently has 38 centers of excellence nationwide that have collectively performed over 11,000 regenerative cell procedures with stem cells, growth factors, exosomes, cytokines and secretomes. The outcomes to date have been exceptional for several conditions, and recently the company became the first nationwide to achieve IRB approval for seven different condition categories using umbilical and amniotic tissue.

According to Dr. Greene, the documentary does a very nice job of showing how academic researchers often lag behind innovative technologies in clinical practice. In all the R3 Centers where procedures are done, no patients have had a significant adverse event. They have been very safe, and many lives have been changed with the regenerative cell procedures.

In addition, the documentary discusses the "raging battle" between academics and medical practitioners. Medical doctors are using the technology successfully, and several providers in the documentary explained that there are clinical trial results available. They just aren't large studies.

In the documentary, Elliott spoke with many leading researchers, practicing, doctors, patients and those with significant industry experience such as Dr. Greene. Over ten people interviewed in the documentary discussed just how many improvements they have personally seen in patients. This included Dr. Mary Gendy of the Los Angeles Dodgers, who said she thought it would be a "disservice not to offer it to her patients."

Currently, a 12 minute abridged version of the hour long documentary can be viewed on the R3 Stem Cell website. This is where Dr. Greene's interview footage appears. R3's Centers have been at the forefront of offering umbilical cord stem cell therapy along with other regenerative procedures that have been safe, nonsurgical and entail absolutely minimal downtime.

For those interested in learning more about regenerative cell therapies using stem cells, growth factors, exosomes and cytokines, visit https://R3StemCell.com or call (844) GET-STEM.

Read the full story at https://www.prweb.com/releases/dr_david_greene_with_r3_stem_cell_interviewed_for_acclaimed_documentary/prweb16322740.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Professor Sir David Weatherall, M.D., recieves 2013 Wallace H. Coulter Award
2. David Allis, pioneer in epigenetics, to receive prestigious Japan Prize
3. New journal, Brain and Gut, edited by David Perlmutter, best-selling author of Grain Brain, launching in summer 2014
4. David and Goliath: How a tiny spider catches much larger prey
5. When David beats Goliath
6. NXT-ID, Inc.s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC.
7. VetStem Biopharma is Pleased to Share the Success Story of Ava who was Treated with VetStem Cell Therapy by Dr. David Luck
8. More food and greener farming with specialised transporters for plants
9. Elevated carbon dioxide making arid regions greener
10. Making hydrogenation greener
11. A greener, more sustainable source of ingredients for widely used plastics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/4/2019)... MEMPHIS, Tenn. (PRWEB) , ... June 04, 2019 ... ... in contract manufacturing of orthopedic medical devices, today announced Q1-19 revenues of $31M, ... the industry combined with successful roll-out of strategic investments & operational excellence initiatives ...
(Date:6/4/2019)... ... , ... Most preclinical EEG visualization platforms offer tools intended ... on variations of amplitude, frequency or spike train detection. In the clinic, however, ... complexity and variability of the signal, and automation tools are used only in ...
(Date:6/1/2019)... FREDERICK, Md. (PRWEB) , ... May 31, 2019 ... ... legal firm Wilson Sonsini Goodrich & Rosati recently invested in BioFactura’s $6M Series ... WSGR, BioFactura is now securing value-added institutional investors who bring significant financial and ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today in ... are able to incorporate into human CD34+ cells, modifying their gene expression and ... increased the cells’ ability to lodge into bone marrow. This research performed by ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... from the USPTO providing proprietary interest to our methodology, processes, and diagnostic ... DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study released today in ... for the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) ... deliver CM into the injured kidney, where it helped restore function and regenerate ...
(Date:5/15/2019)... , ... May 15, 2019 , ... Milton Hershey School® ... recognition for his work within the biomedical industry, where he is changing lives by ... devices. , “William Harding epitomizes the vision of our founders – Milton and ...
Breaking Biology Technology: